As of July 2026, 1 paid clinical trial is testing Tamoxifen in Mankato, Minnesota. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Mankato, MN at 14 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mayo Clinic Health Systems-Mankato | Advanced Lung Non-Small Cell Carcinoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 10 |
| Mayo Clinic Health System-Mankato | Acute Kidney Injury, Community-acquired Pneumonia, Localized Prostate Adenocarcinoma | 5 |
| Mayo Clinic Health System - Mankato | Biochemically Recurrent Prostate Carcinoma, Indolent B-Cell Non-Hodgkin Lymphoma, Limb Pain, Phantom | 4 |
| Mankato Clinic | Depressive Disorder, Major, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | 3 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| GSK Investigational Site | Chickenpox | 1 |
| JAVARA Inc, - Mankato Clinic | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Mankato Clinic - East Main Street - Javara - PPDS | Type II Diabetes Mellitus | 1 |
| Mankato Clinic Ltd | Lumbar Spinal Stenosis | 1 |
| Mankato Clinic/ Javara Research Ltd | Irritable Bowel Syndrome With Constipation (IBS-C) | 1 |
| Mayo Clinic - Mankato | Breast Cancer | 1 |
| Mayo Clinic Health System In | Lumbar Spinal Stenosis | 1 |
| Mayo Clinic Health System in Mankato | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Chemotherapy-Related Nausea and/or Vomiting | 1 |
Recruiting trials in Mankato grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 32 recruiting clinical trials in Mankato, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Mankato compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Mankato include Obesity (3), Anatomic Stage I Breast Cancer AJCC v8 (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mankato on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Mankato include Mayo Clinic Health Systems-Mankato, Mayo Clinic Health System-Mankato, Mayo Clinic Health System - Mankato, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Mankato are Cancer & tumors (14), Diabetes & metabolic (4), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.